Uso de antipsicóticos atípicos no tratamento da esquizofrenia no Sistema Único de Saúde do Brasil: estudo de coorte, 2008-2017 / Uso de antipsicóticos atípicos en el tratamiento de la esquizofrenia en el Sistema Único de Salud de Brasil: estudio de 2008 a 2017 / Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017

Objective: to investigate sociodemographic and clinical characteristics of users of atypical antipsychotics receiving care via the Specialized Component of Pharmaceutical Assistance (Componente Especializado da Assistência Farmacêutica - CEAF), for the treatment of schizophrenia in Brazil, between 2008 and 2017. Methods: this was a retrospective cohort study using records of the authorizations for high complexity procedures retrieved from the Outpatient Information System of the Brazilian National Health System, from all Brazilian states. Results: of the 759,654 users, 50.5% were female, from the Southeast region (60.2%), diagnosed with paranoid schizophrenia (77.6%); it could be seen a higher prevalence of the use of risperidone (63.3%) among children/adolescents; olanzapine (34.0%) in adults; and quetiapine (47.4%) in older adults; about 40% of children/adolescents were in off-label use of antipsychotics according to age; adherence to CEAF was high (82%), and abandonment within six months was 24%. Conclusion: the findings expand knowledge about the sociodemographic and clinical profile of users and highlight the practice of off-label use.

Objetivo: investigar las características sociodemográficas y clínicas de los usuarios de antipsicóticos atípicos, atendidos por el Componente Especializado de Asistencia Farmacéutica (CEAF) para el tratamiento de la esquizofrenia en Brasil, de 2008 a 2017. Métodos: estudio de cohorte retrospectivo utilizando registros de autorizaciones de trámites de alta complejidad del Sistema de Información Ambulatorio del SUS, de todos los estados brasileños. Resultados: de los 759.654 usuários identificados, el 50,5% era del sexo feminino de la región Sudeste (60,2%), diagnosticadas con esquizofrenia paranoide (77,6%). Hubo una mayor prevalencia de risperidona (63,3%) entre niños y adolescentes; de olanzapina (34,0%) en adultos; y quetiapina (47,4%) en ancianos. Alrededor del 40% de los niños/adolescentes estaba bajo uso no autorizado de antipsicóticos según la edad. La adherencia al CEAF fue alta (82%), y la deserción a los seis meses fue del 24%. Conclusión: los hallazgos amplían el conocimiento sobre el perfil sociodemográfico y clínico de los usuarios y destacan la práctica del uso off-label.

Objetivo: investigar características sociodemográficas e clínicas de usuários de antipsicóticos atípicos assistidos pelo Componente Especializado da Assistência Farmacêutica (CEAF), para tratamento da esquizofrenia no Brasil, de 2008 a 2017. Métodos: estudo de coorte retrospectivo utilizando registros das autorizações de procedimentos de alta complexidade do Sistema de Informações Ambulatoriais do Sistema Único de Saúde, de todos os estados brasileiros. Resultados: dos 759.654 usuários, 50,5% eram do sexo feminino, da região Sudeste (60,2%), diagnosticados com esquizofrenia paranoide (77,6%); observou-se maior prevalência de uso da risperidona (63,3%) entre crianças/adolescentes; de olanzapina (34,0%), em adultos; e quetiapina (47,4%), nos idosos; cerca de 40% das crianças/ adolescentes estavam sob uso off-label de antipsicóticos segundo a idade; a adesão ao CEAF foi alta (82%), e o abandono em seis meses foi de 24%. Conclusão: os achados ampliam o conhecimento sobre perfil sociodemográfico e clínico dos usuários e destacam a prática do uso off-label.

El trastorno del lenguaje de las personas con esquizofrenia y su relación con la gravedad y la funcionalidad / The language disorder of people with schizophrenia and its relationship with severity and functionality

RESUMEN: Objetivo: estudiar las características del lenguaje en pacientes que padecen esquizofrenia u otros trastornos psicóticos. Método: 55 pacientes diagnosticados de esquizofrenia (50) y trastorno esquizoafectivo (5). Se aplica la escala TLC de Andreasen, la escala EEAG para la funcionalidad, la CGI para la gravedad. Se recogen datos sociodemográficos. Resultados: Las medias son: edad: 61,47 años, internamiento: 19,47 años, CGI: 5,8, EEAG: 32,5. La subescala de desconexión de la TLC puntúa de media: 8,43, y la de Subproducción verbal: 1,2. La desconexión correlaciona negativamente con EEAG, y positivamente con CGI. La Subproducción verbal correlaciona con CGI. Conclusiones: Los participantes presentan un grado de gravedad elevado y de funcionalidad bajo. Presentan alteraciones importantes del lenguaje, particularmente de pobreza del habla, pero también de desconexión verbal. Con puntuaciones que varían de leve a moderado. Ambas subescalas correlacionan con gravedad. Además, la desconexión es mayor en los pacientes con peor funcionalidad. La alteración del lenguaje en esquizofrenia está relacionada con la gravedad y la funcionalidad, lo cual tiene importantes consecuencias en la vida de las personas que padecen esta enfermedad.

ABSTRACT Objective: to study the characteristics of language in patients suffering from schizophrenia or other psychotic disorders. Method: 55 patients diagnosed with schizophrenia (50) and schizoaffective disorder (5). The Andreasen TLC scale, the EEAG scale for functionality and the CGI for gravity are applied. Sociodemographic data are collected. Results: Mean age: 61.47 years, mean years hospitalized: 19.47 years, CGI: 5.8, EEAG: 32.5. The TLC disconnection subscale scores on average: 8.43, and the Verbal Underproduction: 1.2. Disconnection correlates negatively with EEAG, and positively with CGI. Verbal underproduction correlates with CGI. Conclusions: The participants present a high degree of severity and low functionality. They present significant language alterations, poor speech, and verbal disconnection. With scores ranging from mild to moderate. Both subscales correlate with severity. In addition, the Disconnection is greater in patients with worse functionality. Language impairment in schizophrenia is related to severity and functionality, which has important consequences in the lives of people with this disease.

Linguagem e comunicação na perspectiva do sujeito com esquizofrenia / Language and communication from the perspective of people with schizophrenia / Lenguaje y comunicación desde la perspectiva del sujeto con esquizofrenia

Introdução: a esquizofrenia apresenta um conjunto de sintomas cognitivos, psicóticos, afetivos e emocionais que influenciam a linguagem e o processo comunicativo. Objetivo: refletir sobre o impacto das manifestações linguístico-discursivas da esquizofrenia na comunicação, a partir da perspectiva de sujeitos com esse transtorno mental, além de descrever as principais manifestações linguísticas presentes no discurso desses indivíduos. Método: estudo transversal, descritivo e qualitativo, com modelo de amostragem não probabilística por conveniência, realizado em um Centro de Atendimento Psicossocial. Realizou-se análise de prontuários e entrevista semiestruturada com usuários do serviço de saúde diagnosticados com esquizofrenia. Os resultados foram submetidos à análise estatística descritiva, sendo que as entrevistas foram exploradas de forma qualitativa por meio da "Análise Temática do Conteúdo", após transcrição das falas na íntegra. Resultados: metade dos participantes relatou satisfação e conforto comunicativo, enquanto a outra metade informou dificuldade de comunicação associada a sentimentos de frustração, má disposição, nervosismo e receio de falar em público. Tais sentimentos parecem estar relacionados à postura de desvalorização e estigma do interlocutor perante o discurso de pessoas com esquizofrenia. Observaram-se as seguintes manifestações linguístico-discursivas: descarrilamento e alogia. Não é possível afirmar que uma das manifestações linguístico-discursivas observadas nos participantes, a alogia, esteja associada, exclusivamente, à sintomatologia do transtorno mental, visto que a condição de segregação e estigma social pode ser um fator determinante na redução da produção do discurso. Conclusão: os sintomas de linguagem característicos da esquizofrenia impactam as relações de comunicação dos sujeitos diagnosticados com esse transtorno mental.

Introduction: schizophrenia has a set of cognitive, psychotic, affective and emotional symptoms that influence language and the communicative process. Objective: to reflect on the impact of linguistic-discursive manifestations of schizophrenia on communication, from the perspective of individuals with this mental disorder, in addition to describing the main manifestations present in the speech of these individuals. Method: cross-sectional, descriptive and qualitative study, with a non-probabilistic sampling model for convenience, carried out in a Psychosocial Service Center. Analyses of medical records and semi-structured interviews with users of the health service, diagnosed with schizophrenia, were performed. The results were subjected to descriptive statistical analysis, and the interviews were explored in a qualitative way through the "Thematic Content Analysis", after transcribing the speeches. Results: half of the participants reported satisfaction and communicative comfort, while the other half reported communication difficulties, associated with feelings of frustration, nervousness and fear of speaking in public. Such feelings seem to be related to the attitude of devaluation and stigma of the interlocutor regarding the speech of people with schizophrenia. The following discursive linguistic manifestations were observed: derailment and allogy. It is not possible to state that one of the linguistic-discursive manifestations observed in the participants, the allogy, is associated exclusively with the symptoms of mental disorder, since the condition of segregation and social stigma can be a determining factor in reducing the production of speech. Conclusion: the language symptoms characteristic of schizophrenia impact the communication relationships of subjects diagnosed with this mental disorder.

Introducción: la esquizofrenia tiene un conjunto de síntomas cognitivos, psicóticos, afectivos y emocionales que influyen en el lenguaje y el proceso comunicativo. Objetivo: Reflexionar sobre el impacto de las manifestaciones lingüístico-discursivas de la esquizofrenia en la comunicación, desde la perspectiva de sujetos con este trastorno mental, además de describir las principales manifestaciones presentes en el discurso de estos individuos. Método: estudio transversal, descriptivo y cualitativo, con un modelo de muestreo no probabilístico por conveniencia, realizado en un Centro de Servicios Psicosociales. Se realizaron análisis de historias clínicas y entrevistas semiestructuradas a usuarios del servicio de salud, diagnosticados de esquizofrenia. Los resultados fueron sometidos a análisis estadístico descriptivo, y las entrevistas fueron exploradas de manera cualitativa a través del "Análisis de contenido temático", luego de transcribir los discursos en forma íntegra. Resultados: la mitad de los participantes reportó satisfacción y comodidad comunicativa, mientras que la otra mitad reportó dificultades de comunicación, asociadas con sentimientos de frustración, nerviosismo y miedo a hablar en público.Tales sentimientos parecen estar relacionados con la actitud de desvalorización y estigma del interlocutor con respecto al discurso de las personas con esquizofrenia. Se observaron las siguientes manifestaciones lingüísticas discursivas: descarrilamiento y alogía. No es posible afirmar que una de las manifestaciones lingüístico-discursivas observadas en los participantes, la alología, esté asociada exclusivamente a los síntomas del trastorno mental, ya que la condición de segregación y estigma social puede ser un factor determinante en la reducción de la producción del habla. Conclusión: los síntomas del lenguaje característicos de la esquizofrenia impactan las relaciones de comunicación de los sujetos diagnosticados con este trastorno mental.

Percepción sobre los clubes de integración psicosocial para personas con esquizofrenia en Lima, Perú / Perception about psychosocial integration clubs for people with schizophrenia in Lima, Peru

RESUMEN Objetivo: Conocer la percepción de los usuarios, cuidadores y profesionales de la salud sobre la implementación, funcionamiento y satisfacción relacionada con su participación en los clubes de integración psicosocial (CIP) para personas con diagnóstico de esquizofrenia en dos distritos de Lima Norte. Materiales y métodos: Estudio con enfoque metodológico cualitativo. Se realizaron entrevistas a profundidad y 3 grupos focales con 21 participantes, entre usuarios, familiares cuidadores y profesionales de la salud mental. Se recolectó la información en diciembre de 2018 y se analizaron las percepciones sobre el proceso de implementación y satisfacción de los usuarios del club, sus relaciones afectivas y el ocio, su vinculación con las familias y redes sociocomunitarias, así como las limitaciones percibidas. Resultados: La percepción de los usuarios, cuidadores y profesionales de la salud mental fue favorable acerca de la implementación, funcionamiento y satisfacción de los socios como rol integrador y socializador a través de su participación, la reinserción social en actividades normalizadoras en su comunidad, red sanitaria y en el fortalecimiento de vínculos familiares. Los CIP se perciben como espacios de socialización que tienen un significado relevante en la vida de los usuarios. Conclusiones: Los participantes perciben el CIP como un espacio de bienestar y uso de tiempo libre adecuado que contribuye en la rehabilitación de su enfermedad.

ABSTRACT Objective: To know the perception of users, caregivers and health professionals about the implementation, operation and satisfaction related to their participation in psychosocial integration clubs (PIC) for people with diagnosis of schizophrenia in two districts of northern Lima. Materials and methods: This study had a qualitative methodological approach. In-depth interviews and 3 focus groups were conducted with 21 participants including users, family caregivers, and mental health professionals. The information was collected in December 2018. We analyzed the perceptions of the implementation process and satisfaction of the club's users, their affective relationships and leisure, their link with families and socio-community networks, as well as the perceived limitations. Results: The perception of club's users, caregivers and mental health professionals was favorable regarding the implementation, functioning and satisfaction of the users, as an integrating and socializing role, through their active participation, social reintegration in normalizing activities with their community, the health network and in the strengthening of family ties. PICs are perceived as spaces for socialization that have a relevant meaning in the lives of users. Conclusions: Participants perceive PICs as a space for well-being and adequate use of free time, which contributes to the rehabilitation of the user's disease.

A severe COVID-19 case with schizophrenia as well as other chronic diseases

The prognosis of COVID-19 (coronavirus disease 2019) is usually poor when it occurs in aged adults or in patients with chronic diseases, which brought a great challenge to clinical practice. Furthermore, widespread depression, anxiety, and panic related to SARS-CoV-2 (severe acute respiratory syndrome-coronavirus 2) infection affected treatment compliance and recovery. Here we report the successful treatment of a 57-year-old male with severe COVID-19, schizophrenia, hypertension, and type 2 diabetes. The patient's negative emotions (such as tension, panic, and anxiety), particularly his aggression and paranoia, seriously hindered treatment, leading to a deteriorating condition. Psychological counseling and supportive psychotherapy were given but the effect was weak. To improve adherence, risperidone and quetiapine fumarate were replaced by olanzapine for anti-schizophrenic treatment to reduce insomnia and anxiety side effects, associated with sedative-hypnotic drugs as well as psychological counseling. The treatment compliance of the patient improved significantly. The patient's serum alanine aminotransferase increased abnormally in the late stage of hospitalization, suggesting potential liver damage after complex medication strategies. We also monitored the changes of lymphocyte subsets and retrospectively analyzed the virus-specific antibody response. The results suggested that dynamic monitoring of lymphocyte subsets and virus-specific antibody response could facilitate disease progression evaluation and timely treatment plan adjustments. An effective psychotropic drug intervention associated with psychological counselling and psychotherapy are essential for the successful adherence, treatment, and rehabilitation of psychiatric disorders in COVID-19 patients.

Lifestyle behaviors among 4,343 Brazilian adults with severe mental illness and 55,859 general population controls: data from the Brazilian National Health Survey

Objective: To analyze the association between severe mental illnesses and health behaviors among Brazilian adults. Methods: We used data from the Brazilian National Health Survey, a large nationally representative cross-sectional study conducted in 2013 among 60,202 adults (≥ 18 years). Clinical diagnoses (major depressive disorder, bipolar disorder and schizophrenia), lifestyle behaviors (leisure-time physical activity, TV viewing, tobacco use and the consumption of alcohol, sweets, and soft drinks) and potential confounders (chronological age, race, educational and employment status) were self-reported. Logistic regression models were used to examine the associations between severe mental illness and lifestyle behaviors, adjusting for confounders. Results: Schizophrenia (n=41) was associated with lower odds of physical activity (OR 0.08 [95%CI 0.01-0.58]). Major depressive disorder (n=4,014) was associated with higher odds of TV viewing (OR 1.34 [95%CI 1.12-1.61]), tobacco use (OR 1.37 (95%CI 1.18-1.58]), consumption of sweets (OR 1.34 (95%CI 1.15-1.55]) and consumption of soft drinks (OR 1.24 (95%CI 1.06-1.45]). There were no significant associations between bipolar disorder (n=47) and any lifestyle behaviors. Conclusions: Schizophrenia was associated with lower physical activity, while major depressive disorder was associated with increased TV viewing, tobacco use, and consumption of sweets and soft drinks. These findings reinforce the need for prevention and treatment interventions that focus on people with severe mental illness in Brazil.

Prevalence of mental disorders among elderly men: a systematic review and meta-analysis

ABSTRACT BACKGROUND: Elderly men have been characterized as a group vulnerable to suicide, motivated by loneliness, loss of loved ones and feelings of uselessness to family members. OBJECTIVES: To ascertain the prevalence of different mental disorders among elderly men who attempted suicide. DESIGN AND SETTING: Systematic review of observational studies developed as a result of a partnership between two postgraduate schools (Lagarto and Uberlândia). METHODS: An electronic search was performed in eight electronic databases, including "grey literature", in January 2019. Observational studies that assessed mental disorders among men older than 60 years who attempted suicide were eligible for inclusion. RESULTS: Among the disorders evaluated, mood disorders had the highest prevalence (42.0%; 95% confidence interval, CI: 31.0-74.0%; I2: 0.0%; P = 0.763), followed by substance use-related disorders (41.0%; 95% CI: 8.0-74.0%; I2: 96.4; P < 0.001) and, lastly, schizophrenic disorders (5.0%; 95% CI: 0.0%-14.0%; I2: 80.3%; P = 0.024). CONCLUSIONS: It seems that mood disorders and substance use-related disorders are quite prevalent among elderly men with mental disorders who attempted suicide. It is important to consider the role of healthcare services in making early diagnoses of mental disorders among elderly men, in order to diminish the chances of suicide attempts among them. SYSTEMATIC REVIEW REGISTRATION: CRD42018105981.

Necesidades de atención en salud mental y uso de servicios en población mexicana con trastornos mentales graves / Mental health care needs and use of services in Mexican population with serious mental disorders

Resumen: Objetivo: Analizar las demandas de atención de los trastornos mentales graves (TMG) y factores asociados con la utilización de servicios en México. Material y métodos: Se llevó a cabo un estudio analítico transversal en dos fases: la primera con una base de datos nacional de servicios disponibles y su utilización; la segunda, una muestra de registros médicos de un hospital psiquiátrico. Resultados: La esquizofrenia es el TMG más prevalente; más de 50% de hospitalizados fueron hombres, con edad promedio 37 años. La utilización de servicios estuvo asociada con la edad (β=1.062; p=.000), ingreso familiar (β=1.000, p=.000) y no tener ocupación (β=3.407; p=.000). La población con esquizofrenia tiene cuatro veces más la probabilidad de requerir estar exenta de pago (β=4.158; p=.000). Conclusiones: La población con TMG es más vulnerable por la discapacidad funcional y social asociada; requiere de intervenciones específicas de salud acompañadas de una política de protección financiera adaptada a sus necesidades de atención.

Abstract: Objective: To analyze the mental health care needs of the serious mental disorders (SMD) and factors associated with the use of services in Mexico. Materials and methods: A cross-sectional analytical study was conducted in two phases, the first with a national database of available services and its utilization; the second, a sample of medical records of a psychiatric hospital. Results: Schizophrenia is the most prevalent MDS; more than 50% of those hospitalized were male, with an average age of 37 years. The use of services was associated with age (β=1.062, p=.000), family income (β=1.000, p=.000) and no laboral occupation (β=3.407, p=.000). The population with schizophrenia is four times more likely to require to be exempt from payment (β=4.158, p=.000). Conclusions: The population with SMD as schizophrenia is more vulnerable due to the associated functional and social disability and it requires specific heath interventions and a financial protection policy adapted to their mental health care needs.

Implicações odontológicas do acometimento pela esquizofrenia / Dental Implications of Schizophrenia Impairment

A esquizofrenia consta de patologia neuropsiquiátrica crônica, heterogênea, complexa, debilitante de origem multifatorial e etiologia desconhecida, que aflige ambos os gêneros, masculino e feminino, sem distinção por etnia ou raça. Ocorre desorganização dos processos mentais e os indivíduos afetados passam a possuir uma relação de dependência para com seus cuidadores, geralmente familiares. Existem repercussões em âmbito odontológico advindas da doença. O objetivo deste artigo foi evidenciar as implicações odontológicas que manifestam-se nos doentes em decorrência da presença da esquizofrenia. Realizou-se revisão bibliográfica acerca das implicações odontológicas do acometimento pela esquizofrenia com busca nas bases de dados: PUBMED, LILACS, Google Acadêmico. Pacientes esquizofrênicos, muitas vezes, recusam-se a submeter-se a intervenções odontológicas e médicas. Pode-se conviver com aversão aos cuidados odontológicos por parte desses indivíduos, em decorrência dos transtornos psíquicos presentes. A higienização bucal inexiste ou é realizada precariamente e concomitantemente pode ocorrer a presença de xerostomia por ação medicamentosa, o que implica num quadro desfavorável com manifestações de cárie dentária e doenças periodontais. No contexto geral, o perfil dos problemas odontológicos que acometem pacientes esquizofrênicos, advém do emprego continuado de medicamentos; hábitos alimentares preconizados e negligência na realização do autocuidado e na eliminação de biofilme dentário, que acumula-se. O conhecimento e a conscientização prévia acerca das manifestações clínicas da esquizofrenia pelo cirurgião dentista contactante dos pacientes e familiares é de extremada importância no desfecho do tratamento odontológico a ser realizado. (AU)

Schizophrenia consists of chronic, heterogeneous, complex, debilitating neuropsychiatric pathology of multifactorial origin and unknown etiology that afflicts both genders, male and female, regardless of ethnicity or race. Disorganization of mental processes occurs and affected individuals have a relationship of dependence with their caregivers, usually family members. There are repercussions in the dental field arising from the disease. The aim of this paper was to highlight the dental implications that manifest themselves in patients due to the presence of schizophrenia. A bibliographic review about the dental implications of schizophrenia involvement was performed, searching the databases: PUBMED, LILACS, Google Scholar. Schizophrenic patients often refuse to undergo dental and medical interventions. One can live with aversion to dental care on the part of these individuals, due to the psychic disorders present. Oral hygiene does not exist or is performed poorly and concomitantly there may be the presence of xerostomia by drug action, which implies an unfavorable picture with manifestations of dental caries and periodontal diseases. In the general context, the profile of dental problems affecting schizophrenic patients derives from the continued use of medications; recommended eating habits and negligence in self-care and in the elimination of dental biofilm, which accumulates. Prior knowledge and awareness about the clinical manifestations of schizophrenia by the contacting dental surgeon of patients and family members is extremely important in the outcome of the dental treatment to be performed. (AU)

Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies

Objective: To analyze the efficacy and safety of paliperidone palmitate 3-monthly (PP3M) in Latin American patients with schizophrenia vs. rest-of-world (ROW). Methods: We analyzed data from two multinational, double-blind (DB), randomized, controlled phase 3 studies including patients with schizophrenia (DSM-IV-TR) previously stabilized on PP1M/PP3M (open-label [OL] phase). Patients were randomized to PP3M or PP1M (noninferiority study A) and PP3M or placebo (study B) in DB phase. The subgroup analysis included Latin American (Argentina, Brazil, Colombia, Mexico) patients. Primary efficacy endpoints were relapse-free rates (study A) and time-to-relapse (study B). Results: In study A, 63/71 (88.7%) and in study B 38/43 (88.4%) Latin American patients completed the DB phase. In study A, relapse-free percentage was similar in Latin America (PP3M: 97%, PP1M: 100%) and ROW (PP3M: 91%, PP1M: 89%). In study B, median time-to-relapse was not estimable in the Latin American subgroup for either placebo or PP3M groups, nor for the ROW PP3M group; the median time-to-relapse in the ROW placebo group was 395 days. Caregiver burden improved in patients switching from oral antipsychotics (OL baseline) to PP3M/PP1M in DB phase (Involvement Evaluation Questionnaire score mean ± SD change, -9.4±15.16; p < 0.001). Treatment emergent adverse events with PP3M during DB phase were similar in Latin America (study A: 24/34 [70.6%]; study B: 15/21 [71.4%]) and ROW (study A: 318/470 [67.7%]; study B: 84/139 [60.4%]) subgroups. Conclusion: PP3M was efficacious and showed no new safety concerns in patients with schizophrenia from Latin America, corroborating ROW findings. Clinical trial registration: NCT01515423, NCT01529515

Schizophrenia TreAtment with electRic Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial / Tratamento da esquizofrenia com estimulação transcraniana por corrente contínua (ETCC): fundamentação teórica e objetivos de um ensaio clínico randomizado, duplo-cego, controlado por simulação

Abstract Introduction Schizophrenia is a severe mental disorder. While some antipsychotic medications have demonstrated efficacy in treating positive symptoms, there is no widely recognized treatment for negative symptoms, which can cause significant distress and impairment for patients with schizophrenia. Here we describe the rationale and design of the STARTS study (Schizophrenia TreAtment with electRic Transcranial Stimulation), a clinical trial aimed to test the efficacy of a non-pharmacological treatment known as transcranial direct current stimulation (tDCS) for treating the negative symptoms of schizophrenia Methods The STARTS study is designed as a randomized, sham-controlled, double-blinded trial evaluating tDCS for the treatment of the negative symptoms of schizophrenia. One-hundred patients will be enrolled and submitted to 10 tDCS sessions over the left dorsolateral prefrontal cortex (anodal stimulation) and left temporoparietal junction (cathodal stimulation) over 5 consecutive days. Participants will be assessed using clinical and neuropsychological tests before and after the intervention. The primary outcome is change in the Positive and Negative Syndrome Scale (PANSS) negative subscale score over time and across groups. Biological markers, including blood neurotrophins and interleukins, genetic polymorphisms, and motor cortical excitability, will also be assessed. Results The clinical results will provide insights about tDCS as a treatment for the negative symptoms of schizophrenia, and the biomarker investigation will contribute towards an improved understanding of the tDCS mechanisms of action. Conclusion Our results could introduce a novel therapeutic technique for the negative symptoms of schizophrenia. Clinical trial registration: ClinicalTrials.gov, NCT02535676 .

Resumo Introdução A esquizofrenia é um transtorno mental grave. Embora alguns medicamentos antipsicóticos tenham demonstrado eficácia no tratamento de sintomas positivos, não há tratamento amplamente reconhecido para sintomas negativos, o que pode causar sofrimento e prejuízo significativos para pacientes com esquizofrenia. Aqui descrevemos a fundamentação teórica e o design do estudo STARTS (Schizophrenia TreAtment with electRic Transcranial Stimulation), um ensaio clínico destinado a testar a eficácia de um tratamento não farmacológico conhecido como estimulação transcraniana por corrente contínua (ETCC) para tratar os sintomas negativos da esquizofrenia. Métodos O estudo STARTS foi concebido como um ensaio clínico randomizado, controlado por simulação, duplo-cego, avaliando a ETCC para o tratamento dos sintomas negativos da esquizofrenia. Cem pacientes serão incluídos e submetidos a 10 sessões de ETCC sobre o córtex pré-frontal dorsolateral esquerdo (estimulação anódica) e a junção temporoparietal esquerda (estimulação catodal) durante 5 dias consecutivos. Os participantes serão avaliados através de testes clínicos e neuropsicológicos antes e após a intervenção. O desfecho primário é a mudança na pontuação da subescala negativa da Escala da Síndrome Positiva e Negativa (Positive and Negative Syndrome Scale [PANSS]) ao longo do tempo e entre os grupos. Marcadores biológicos, incluindo neurotrofinas e interleucinas do sangue, polimorfismos genéticos e excitabilidade cortical motora, também serão avaliados. Resultados Os resultados clínicos fornecerão informações sobre a ETCC como um tratamento para os sintomas negativos da esquizofrenia, e a investigação dos biomarcadores contribuirá para uma melhor compreensão dos mecanismos de ação da ETCC. Conclusão Nossos resultados podem trazer uma nova técnica terapêutica para o tratamento dos sintomas negativos da esquizofrenia. Registro do ensaio clínico: ClinicalTrials.gov, NCT02535676.

Quality of life in schizophrenic patients: the influence of sociodemographic and clinical characteristics and satisfaction with social support / Qualidade de vida nas pessoas com esquizofrenia: a influência das características sociodemográficas e clínicas e da satisfação com o suporte social

Abstract Objective To evaluate the relationship of sociodemographic and clinical characteristics and satisfaction with social support with the quality of life of schizophrenic patients. Methodology This study included a sample of 268 participants. An interview was conducted to obtain sociodemographic and clinical data, supplemented with two assessment tools used to evaluate quality of life (World Health Organization Quality of Life instrument-Abbreviated version - WHOQOL-Bref) and satisfaction with social support (Social Support Satisfaction Scale - SSSS). Descriptive and inferential analyses were performed. Results Most individuals were male (63.4%), with a mean age of 45.4 years, single (85.4%), living with their family (62.3%) and unemployed (90.3%). As for clinical characteristics, most had the disease for less than 20 years (50.7%), and 55.6% had at least one hospitalization within the last 5 years. Being employed and having had no hospitalization within the last 5 years were positively correlated with one or more WHOQOL-Bref domains. The results of the variables intimacy (p<0.001) and satisfaction with friends (p<0.001) were independently related to the total WHOQOL-Bref score. Conclusion Having a job, having had no hospitalization within the last 5 years and having greater satisfaction with social support are factors that positively influence quality of life among schizophrenics. It is therefore crucial that the psychosocial rehabilitation of patients with schizophrenia take these factors into account, increasing the support network, preventing relapses and promoting occupational activities.

Resumo Objetivo Avaliar a relação entre as características sociodemográficas e clínicas e a satisfação com o suporte social com a qualidade de vida dos doentes com esquizofrenia. Métodos A amostra do estudo é de 268 participantes. Foi realizada uma entrevista para obter os dados sociodemográficos e clínicos e aplicados dois questionários para avaliar a qualidade de vida (World Health Organization Quality of Life instrument-Abbreviated version - WHOQOL-Bref) e a satisfação com o suporte social (Escala de Satisfação com o Suporte Social - ESSS). Foram efetuadas análises descritivas e inferenciais. Resultados A maioria dos indivíduos era do gênero masculino (63,4%), com uma média de idade de 45,4 anos, solteiros (85,4%), vivendo com a família (62,3%) e desempregados (90,3%). Relativamente às características clínicas, 50,7% tinham a doença há menos de 20 anos, e 55,6% estiveram internados pelo menos uma vez nos últimos 5 anos. Os resultados demonstraram que estar empregado e não ter sido internado nos últimos 5 anos estão positivamente relacionados com um ou mais domínios da WHOQOL-Bref. A satisfação com a intimidade (p<0,001) e a satisfação com os amigos (p<0,001) foram independentemente associados ao escore total da WHOQOL-Bref. Conclusão Ter emprego, não ter hospitalizações nos últimos 5 anos e estar satisfeito com o suporte social são fatores que influenciam positivamente a qualidade de vida dos doentes com esquizofrenia. Por conseguinte, é crucial que esses fatores sejam levados em conta nos programas de reabilitação com o suporte social, aumentando a rede de suporte, evitando recaídas e promovendo atividades ocupacionais.

Estratégias de enfrentamento de mulheres cuidadoras de pessoas com esquizofrenia / Caregiver women's coping strategies toward schizophrenia bearing people / Las estrategias de afrontamiento de las mujeres cuidadores de las personas con esquizofrenia

Objetivo: Objetivo: Conocer las estrategias de afrontamiento utilizadas por mujeres cuidadores de los pacientes con esquizofrenia. Método: Estudio de carácter exploratorio descriptivo con enfoque cualitativo realizado Atención Sobral Centro Psicosocial con 15 mujeres cuidadores de pacientes con esquizofrenia en el periodo de julio 2015 a junio 2016 a partir de entrevistas. Resultados: Los factores desencadenantes de estrés reportado por las mujeres fueron: estrés físico y psicológico para el cuidado diario del paciente con esquizofrenia; la dificultad de hacer frente a la enfermedad y su aceptación y; miedo a morir y dejar a la persona sola. Las estrategias de supervivencia por ellos estaban buscando apoyo espiritual y la expresión religiosa de los sentimientos para el alivio del estrés, uso de medicamentos psicotrópicos y la participación en actividades grupo. Conclusión: Es importante que las instituciones de salud, especialmente aquellos que atienden a las personas con trastorno mental apoyen al cuidador

Objetivo: Conhecer as estratégias de enfrentamento utilizadas por mulheres cuidadoras de pacientes com esquizofrenia. Método: Estudo de natureza exploratório-descritivo, com abordagem qualitativa, realizado no Centro de Atenção Psicossocial Geral de Sobral-CE, com 15 mulheres cuidadoras de pacientes com esquizofrenia, nos períodos de julho de 2015 a junho de 2016, a partir de entrevistas. Resultados: Os fatores desencadeantes de estresse relatados pelas mulheres foram: o desgaste físico e psicológico pelo cuidado diário com o portador de esquizofrenia; a dificuldade de lidar com a doença, sua aceitação e medo de morrer e; deixar o seu ente sozinho. As estratégias de enfrentamento apresentadas por elas foram: busca de apoio espiritual e religioso, expressão de sentimentos para alívio do estresse, uso de medicações psicotrópicas e participação em atividades grupais. Conclusão: É importante que as instituições de saúde, em especial aquelas que prestam cuidados à pessoa com transtorno mental, ofertem apoio ao cuidador

Objective: The study's goal has been to know the coping strategies used by caregiver women toward patients bearing schizophrenia. Methods: It is a descriptive-exploratory study with a qualitative approach that was carried out in the general Psychosocial Care Center of Sobral city in Ceará State. The research had 15 caregiver women of patients bearing schizophrenia, and was performed from July 2015 to June 2016, based on interviews and after approval by the Research Ethics Committee from the Universidade Estadual Vale do Acaraú, under the CAAE 53208616.3.0000.5053. Results: The stress-triggering factors reported by the women were the following: physical and psychological exhaustion due to daily care with the schizophrenic patient; difficulty in dealing with the disease, their acceptance and fear of dying; and leaving the patient alone. The coping strategies presented by them were the following: seeking for spiritual and religious support; expression of feelings for stress relief; use of psychotropic medications; and participation of in-group activities. Conclusion: It is important that health care institutions can offer support to the caregiver

Variables demográficas y clínicas relacionadas con la carga y el afrontamiento de los cuidadores de personas diagnosticadas de esquizofrenia / Clinical and Demographic Variables Associated Coping and the Burden of Caregivers of Schizophrenia Patients

RESUMEN Objetivo: Analizar la relación de la carga y las estrategias de afrontamiento con las características demográficas de los cuidadores de personas con esquizofrenia, así como las variables demográficas y clínicas de los pacientes. Métodos: Estudio transversal correlacional multicéntrico en el que se evaluó a 70 personas diagnosticadas de esquizofrenia o trastorno esquizoafectivo y 70 cuidadores informales primarios con la escala de sobrecarga del cuidador de Zarit, el cuestionario de estrategias familiares de afrontamiento, la escala para la evaluación de síntomas positivos, la escala para la evaluación de síntomas negativos y la escala breve de evaluación de la discapacidad. Resultados: En este estudio, la carga se correlacionó positivamente con el deterioro del funcionamiento ocupacional y social y presentó asociación negativa con la escolaridad de los pacientes. El escape, la coerción y la comunicación positiva presentaron correlaciones positivas con el deterioro del funcionamiento ocupacional y social de los pacientes. Asimismo, el interés social y las amistades mostraron asociación positiva con la escolaridad de los cuidadores. Además, la ayuda espiritual presentó correlaciones negativas con el deterioro del funcionamiento social y la edad de los pacientes, y la resignación se correlacionó negativamente con la duración del trastorno y la escolaridad de los pacientes. Conclusiones: La carga y la adopción de estrategias de afrontamiento disfuncionales, como el escape y la coerción, se asocian con el deterioro del funcionamiento de los pacientes. Estos hallazgos indican la necesidad de brindar a los cuidadores apoyos ajustados al nivel de funcionamiento del paciente que prevengan la carga del cuidado.

ABSTRACT Objective: To analyze of the relationship between burden of illness and coping strategies and the demographic variables of caregivers, and the demographic and clinical variables of people diagnosed with schizophrenia. Methods: Multicentre correlational cross-sectional study including 70 people diagnosed with schizophrenia, or a schizoaffective disorder, and 70 primary informal caregivers. They were evaluated using Zarit Caregiver Burden Inventory, Family Coping Strategies Questionnaire, Scale for the Assessment of Positive Symptoms, Scale for the Assessment of Negative Symptoms, and the brief Disability Assessment Scale. Results: Burden of illness positively associated with patient impairment in occupational and social functioning, and negatively with education level. Avoidance, coercion and positive communication were positively associated with impairment in occupational and social functioning of patients. Social interest and friendships showed a positive association with the education level of caregivers. Spiritual assistance negatively correlated with impairment in social functioning and patient age, and resignation was negatively associated with length of the disorder and patient education level. Conclusions: Burden and dysfunctional coping strategies, such as avoidance and coercion, are associated with functional impairment of the patient. These findings suggest the need to provide support to caregivers, adjusted to the functional level of the patient, in order to prevent burden of care.

Indirect self-destructiveness in individuals with schizophrenia

Objective: To explore the indirect self-destructiveness syndrome in patients with schizophrenia. Methods: Two hundred individuals with paranoid schizophrenia (117 men and 83 women, mean age 37.15 years), all in remission, were examined using the Polish version of the Chronic Self-Destructiveness Scale. Two hundred well-matched healthy individuals served as a control group. Results: The intensity of indirect self-destructiveness was greater in the schizophrenia group than in controls. The intensity of each manifestation was as follows (in decreasing order): helplessness and passiveness in the face of difficulties (A5), personal and social neglects (A3), lack of planfulness (A4), poor health maintenance (A2), transgression and risk (A1). Conclusion: Patients with schizophrenia displayed more behaviors that were indirectly self-destructive than healthy controls; they scored better than healthy controls only on caring for their own health. The patients showed the lowest intensity of behaviors connected with the active form of indirect self-destructiveness, and the highest intensity of behaviors connected with the passive form. These findings may enable delivery of more effective forms of pharmacological and psychosocial help to patients with schizophrenia.

Estrategias de evaluación en la narración como tarea metacognitiva en personas con esquizofrenia / Narrative evaluation strategies as metacognitive task in subjects with schizophrenia

RESUMEN Objetivo Este estudio procura explorar las diferencias en el componente evaluativo de la estructura narrativa en personas con diagnóstico de esquizofrenia, en comparación con personas con diagnóstico de psicosis afectiva. Método El presente estudio es descriptivo, no experimental, y comprende el análisis de los componentes evaluativos de la narrativa, en entrevistas realizadas a 25 individuos con diagnostico psiquiátrico de esquizofrenia crónica y a 25 individuos diagnosticados de psicosis afectiva crónica, pareados por edad, género y características sociodemográficas. Resultados La relación entre diagnóstico y tipo de evaluación arrojó resultados estadísticamente significativos con un valor de chi cuadrado de 39,880a (p< 0.00). Fue posible observar que en la esquizofrenia existe una mayor inhibición en la elaboración de expresiones que impliquen opiniones, que los relatos tendieron a identificar los hechos independientemente de cómo les afectaron, sugiriendo una limitación de la función intersubjetiva. Conclusión La variable diagnóstico confirma que en la esquizofrenia existe un deterioro funcional en la elaboración de estructuras narrativas y en la articulación del componente evaluativo. En el caso de la psicosis afectiva se manifiestan disfunciones superficiales, sin comprometer su desempeño en la evaluación de las narraciones.

ABSTRACT Purpose This study aims to explore the differences in the evaluative component of the narrative structure in subjects diagnosed with schizophrenia compared to subjects diagnosed with affective psychosis. Methods The present investigation was descriptive, not experimental and it included the analysis of the narration evaluative components of interviews of 25 individuals with psychiatric diagnosis of chronic schizophrenia and 25 of chronic affective psychosis, matched by age, gender and sociodemographic characteristics. Results The relationship between diagnosis and type of evaluation showed statistically significant results with a chi square value of 39.880a (p <0.00). It was possible to observe that in the schizophrenia there is a greater inhibition in the elaboration of expressions that imply opinions and that narratives tended to identify facts regardless of how they affected subjects, suggesting a limitation of intersubjective function. Conclusion The diagnostic variable confirms that in schizophrenia there is a functional deterioration in the process of elaborating narrative structures especially in the articulation of the evaluative component. In the case of the affective psychosis group, superficial dysfunctions were manifested, without compromising their performance in the evaluation of narratives.

Esquizofrenia y su asociación con enfermedades médicas crónicas / The association of schizophrenia with chronic non transmissible diseases

The life expectancy of patients with schizophrenia (SCH) is 11 to 20 years less than the general population. There is an association between SCH and various diseases and chronic conditions, highlighting the cardio-metabolic diseases. This association has been attributed to the use of antipsychotics, however, evidence has also shown intrinsic susceptibility of schizophrenic patients the development of chronic conditions. This review aims to update knowledge about chronic conditions such as cardiometabolic risk and sleep, bone and kidney disorders related to SCH. These patients have a high prevalence of risk behaviors, including smoking and poor diet. They have a worse metabolic profile than the general population and a greater likelihood of developing metabolic syndrome, diabetes and cardiovascular disease. SCH has also been associated with other chronic diseases such as osteoporosis and chronic kidney disease. The high prevalence of these comorbidities in schizophrenic population is not explained solely by the antipsychotic treatment, therefore intrinsic mechanisms associated to SCH are postulated to be associated with these conditions. This new information requires a change in the multidisciplinary medical approach for the study and management of schizophrenic patients.

A evolução dos conceitos sobre as psicoses paranoides tardias (psicoses funcionais do espectro esquizofrênico) / Medical Education. The evolution of concepts about late paranoid psychoses

As psicoses paranoides tardias, psicoses de espectro da esquizofrenia, constituem grupo complexo e heterogêneo de psicoses, assim considerado desde sua primeira descrição por Kraepelin, no início do século 20. Desde então, inúmeras descrições e conceitos surgiram e foram, posteriormente, excluídas, em função de sua visão parcial dessa candente questão psicogeriátrica. O conceito de parafrenia tardia, descrito por Kraepelin, em 1903, foi recuperado, em 1953, por Roth, mantendo muitas de suas características originais, entretanto, também se mostrou insuficiente para a caracterização desse grupo de transtornos psíquicos. As tentativas de obtenção de classificações psiquiátricas, realizadas na contemporaneidade pela Organização Mundial de Saúde ou Associação Americana de Psiquiatria, têm se voltado para os conceitos originais de Kraepelin e Bleuler, especialmente de Kraepelin, mas suas descrições ainda deixam lacunas importantes para que as psicoses funcionais do espectro esquizofrênico sejam diagnosticadas com segurança. Em 1999 surgiu m consenso internacional para o diagnóstico desse grupo de entidades que preenche com mais rigor os critérios para maior índice de acertos quanto ao seu diagnóstico. Esta revisão objetiva apresentar as características que permitem com mais praticidade estabelecer os critérios para o diagnóstico das psicoses paranoides tardias. (AU)

Late-life paranoid psychoses, schizophrenia spectrum psychoses, constitute a complex and heterogeneous group of psychoses, so considered since its first description by Kraepelin, in the early 20th century. Since then, numerous descriptions and concepts have emerged and were subsequently droppedd, in function of his partial view of this burning psychogeriatric question. The concept of late-paraphrenia, described by Kraepelin in 1903, was recovered in 1953 by Roth, maintaining many of its original characteristics, however, it was also insufficient for the characterization of this group of psychic disorders. Attempts to obtain psychiatric ratings, carried out contemporaneously by the World Health Organization or American Psychiatric Association, have turned to the original concepts of Kraepelin and Bleuler, especially of Kraepelin, but their descriptions still leave important gaps for functional psychoses of the schizophrenic spectrum are safely diagnosed. In 1999, an international consensus emerged for the diagnosis of this group of entities that more accurately meets the criteria for a better index of correct diagnosis. This review aims to present the characteristics that allow us to more easily establish the criteria for the diagnosis of late paranoid psychosis. (AU)

Embarazo en pacientes con esquizofrenia / Pregnancy in patients with schizophrenia

Se realizó un estudio descriptivo y de cohorte basado en la revisión de historias clínicas y base de datos del Sistema Informático Perinatal (sip) de las pacientes portadoras de esquizofrenia y embarazadas que consultaron en el Hospital Vilardebó entre 2009-2012. Se estudiaron 35 casos de gestaciones que correspondieron a 30 mujeres. Se identificaron determinadas características sociodemográficas y clínicas: mayor edad en el momento de la gestación, menor planificación del embarazo, menor cantidad de controles prenatales, la mayoría de las consultas psiquiátricas se realizaron durante el puerperio. No se evidenció asociación entre madres con esquizofrenia y menor edad gestacional, menor peso del recién nacido o Apgar bajo, así como tampoco con la presencia de complicaciones obstétricas o neonatales.

A descriptive cohort study was conducted basedon the review of medical records and Perinatal Information System database (sip) of pregnant women with schizophrenia who were assisted atthe State Mental Facility (Hospital Vilardebó) from2009 to 2012. 35 cases of pregnancies which corresponded to 30 women were studied. Certainsocio-demographic and clinical characteristics were identified: age at the time of pregnancy,lower pregnancy planning, less prenatal medicalcare, most psychiatric consultations were heldduring the post-partum period. No associationwere found between mothers with schizophreniaand lower gestational age, low birth weight or low Apgar, nor the presence of obstetric or neonatal complications are evident.

Electroconvulsoterapia en el primer episodio de esquizofrenia: impacto en la evolución / Electroconvulsoterapia in the first episode of schizophrenia: impact on evolution

La esquizofrenia es una patología que evolucionade forma crónica, proclive al deterioro, siendo este último variable de acuerdo con comorbilidades presentes y adherencia al tratamiento integral. Genera alteraciones cognitivas e influye negativamente en el desempeño de quienes la padecen, causando detrimento global de los pragmatismos. La electroconvulsoterapia es una opción terapéutica ampliamente utilizada en nuestro país para tratar sintomatología del humor y episodios psicóticos agudos, entre otros. En la actualidad se sabe que la detección e intervención precoz de un episodio psicótico agudo —el cual puede corresponder al primer episodio psicótico de esquizofrenia —mejora el pronóstico a largo plazo. El objetivo es demostrar si existe un vínculo entre la indicación de electroconvulsoterapia durante el primer episodio psicótico de esquizofrenia y la duración del intervalo libre de internación. Este es un estudio de tipo analítico, observacional, retrospectivo (cohorte histórica) que busca aumentar las evidencias en este amplio campo de investigación. Observamos que el tiempo libre de internación luego de la primera hospitalización no tuvo relación con el hecho de si recibieron electroconvulsoterapia o no; sin embargo, al realizar el análisis de potencia estadístico surge que los resultados no son concluyentes. Se destaca el importante porcentaje de patología dual en este grupo de usuarios: un 39%.

Schizophrenia is a chronic disease, prone todeterioration, the latter being variable accordingto comorbidities and treatment adherence. It generates cognitive impairment and adverselyaffects overall performance, causing deterioration of pragmatisms. Electroconvulsive therapy is awidely used therapeutic option in our countryfor acute affective and psychotic episodes. It iswell known that early detection and interventionof an acute psychotic episode —which maycorrespond to the first psychotic episode of schizophrenia— improves long-term prognosis.This study intended to show whether there is alink between early indication of electroconvulsive therapy during the first episode and timeto relapse and hospital readmission. This is ananalytical, observational, retrospective (historical cohort) study, which aims to increase theevidence in this broad research field. As a resultthere was no link between time to relapse and electro convulsive therapy in the first episode; nevertheless after a post hoc analysis resultsare not conclusive. Dual diagnosis stands outin this group and corresponds to 39%.